Abstract Repository
Documents will be posted here periodically. To receive updates, please make sure the box titled 'email updates' is checked when filling out our online form
Long-term Intrathecal Baclofen Therapy in Ambulatory Multiple Sclerosis Patients
James W. Stark, MD, Armistead D. Williams, MD and Saud A. Sadiq, MD
Multiple Sclerosis Research Center of New York
Effect of Mesenchymal Stem Cell-Derived Neural Progenitors on Demyelination and Immune Cell Infiltration in Mice with Experimental Autoimmune Encephalomyelitis
62nd Annual Meeting of the American Academy of Neurology - Toronto 2010
Neural Repair Using Stem Cells
Use of Autologous Neural Progenitors as a Repair Strategy for Multiple Sclerosis (Violaine K. Harris, Nara Chhua, Pamela Good, and Saud A. Sadiq) was presented in June 2008 at the 6th Annual Meeting of the International Society of Stem Cell Researchers.
Cognition and Cerebellar Dysfunction
Cognition and Cerebellar Dysfunction in Multiple Sclerosis are Associated with Decreased Bri2 Expression (Pamela Good, Niamh O'Hara, Nara Chhua, Violaine K Harris, and Saud A. Sadiq, MD) was presented in April 2008 at the 60th Annual Meeting of the American Academy of Neurology.
Peripheral Blood Dendritic Cells
Peripheral Blood Dendritic Cells Secrete Lower Levels of Pro-Inflammatory Cytokines in Multiple Sclerosis (Edward W.A. Brydon, PhD and Saud A. Sadiq, MD) was presented in April 2008 at the 60th Annual Meeting of the American Academy of Neurology.
Altered Human Pancreatic Ribonuclease
Altered Human Pancreatic Ribonuclease in Multiple Sclerosis (Niamh B O'Hara, BA, Erin Drazich, BA, Qijiang Yan, MD, PhD, Jerry Lin, BA and Saud A. Sadiq, MD) was presented in April 2008 at the 60th Annual Meeting of the American Academy of Neurology.
JC/BK Virus
Detection of JC/BK Virus in Patients with Multiple Sclerosis treated with Natalizumab (Lauren M. Puccio, Jacqueline Dinzey, Christina A. Poopatana, Kathleen V. Barrett, and Saud A. Sadiq, MD) was presented in April 2008 at the 60th Annual Meeting of the American Academy of Neurology.
Increased Fetuin-A Levels in EAE and MS Lesions
Increased Fetuin-A Levels in Acute Demyelinating Lesions in Experimental Autoimmune Encephalomyelitis and Multiple Sclerosis (Qi Jiang Yan, Mustapha Rammal, Jacqueline Dinzey, Nicola R. Donelan, Saud A. Sadiq) was presented in November 2007 at Neuroscience 2007, the 37th annual meeting of the Society for Neuroscience.
Elevated Cerebrospinal Fluid Fetuin-A Levels
Elevated Cerebrospinal Fluid Fetuin-A Levels Are a Marker of Disease Activity in Multiple Sclerosis (Jacqueline Dinzey, Nicola R. Donelan, Qi Jiang Yan, Mustapha Rammal, Saud A. Sadiq) was presented in November 2007 at Neuroscience 2007, the 37th annual meeting of the Society for Neuroscience.
Use of Autologous Mesenchymal Stem Cells for Neural Repair
Use of Autologous Mesenchymal Stem Cells for Neural Repair (Violaine K. Harris, PhD, Pamela Good, BA, Nara Chhua, BA, Saud A. Sadiq, MD) was presented in October 2007 at the 132nd Annual Meeting of the American Neurological Association.
Fetuin-A is a Possible Biomarker of Disease Activity
Fetuin-A is a Possible Biomarker of Disease Activity in Multiple Sclerosis (Mustapha Rammal, Qijiang Yan, Jacqueline Dinzey, Nicola R. Donelan, Saud A. Sadiq, New York, NY) was presented in October 2007 at the 132nd Annual Meeting of the American Neurological Association.
Rituximab Therapy
Rituximab Therapy Markedly Reduces CSF T- and B-Cell Populations in MS (Niamh B. O'Hara, Jacqueline Dinzey, Jessie Kerr, Nicola Donelan, Saud A. Sadiq, New York, NY) was presented in October 2007 at the 132nd Annual Meeting of the American Neurological Association.
Mitoxantrone Therapy-Associated Menstrual Dysfunction
Mitoxantrone Therapy-Associated Menstrual Dysfunction in Patients with Multiple Sclerosis (Jessie A. Kerr, Emily Eisenberg, Saud A. Sadiq, New York, NY) was presented on Thursday, May 3, 2007 at the 59th Annual Meeting of the American Academy of Neurology.
Neural Progenitors from Bone Marrow Stem Cells
The Use of Neural Progenitors Derived from Bone Marrow Mesenchymal Stromal Cells as a Cell-Based Therapy for Multiple Sclerosis (Violaine K. Harris, Nara Chhua, Pamela Good, and Saud A. Sadiq, New York NY) was presented on Monday, June 18, 2007 at the 5th Annual Meeting of the International Society of Stem Cell Researchers.
Biology of Demyelinating Disease
A lecture given by Saud A. Sadiq, MD, on March 11, 2006, at the Columbia University College of Physicians and Surgeons 29th Annual Postgraduate Review Course in Basic and Clinical Neurosciences.
Identification of Specific Electron Transport Chain Abnormalities
Identification of specific electron transport chain abnormalities in amyotrophic lateral sclerosis (J. Lin, A.W. Diamanduros, N. Chhua, S.A. Sadiq, New York, NY) was presented on Tuesday, October 17, 2006 at Neuroscience 2006, the annual meeting of the Society for Neuroscience.
Long-term intrathecal baclofen therapy
Long-term intrathecal baclofen therapy in ambulatory patients with spasticity (S.A. Sadiq, G.C. Wang, New York, NY) was published in the Journal of Neurology in 2006.
Detection of JC/BK Virus in Patients with Multiple Sclerosis treated with Natalizumab
Fetuin A is a Biomarker for Disease Activity and Treatment Efficacy in MS
Monitoring of natalizumab therapy with cerebrospinal fluid activation markers
Molecular characterization of CSF B cell response in multiple sclerosis
Multiplicity in Multiple Sclerosis: What Causes MS?
Repair and Regeneration Through Stem Cell Research
Treating Gait Impairments with Physical Therapy
|
